Overview Performance Dividends Peer Group Options

(KRN) Karnalyte Resources - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA4856722083

KRN: Potash, Magnesium

Karnalyte Resources Inc. (TO:KRN) is a Canadian exploration and development company focused on potash and magnesium products. The company holds 100% ownership of the Wynyard Potash Project, which includes subsurface mineral leases KLSA 010, KL 247A, and KL 246. These leases cover 367 km² of mineral rights in Wynyard, Saskatchewan, a region known for its high-quality potash deposits. Incorporated in 2007 and headquartered in Saskatoon, Saskatchewan, Karnalyte is positioned in a key area for potash production, a critical component in fertilizer manufacturing. The companys assets are strategically located near infrastructure, facilitating potential future development.

Karnalyte Resources Inc. operates in the Fertilizers & Agricultural Chemicals sub-industry, with its common stock listed on the Toronto Stock Exchange (TO) under the ticker symbol KRN. The companys market capitalization is currently 5.59M CAD, with a price-to-book (P/B) ratio of 1.07, indicating its assets are valued near their book value. However, the companys return on equity (RoE) is negative at -32.11, reflecting current operational challenges.

Based on the provided and , the 3-month outlook for Karnalyte Resources Inc. (TO:KRN) is as follows: The stock is trading at 0.16 CAD with a 20-day average volume of 2,000 shares, indicating low liquidity. The 20-day moving average (SMA 20) is 0.10, while the 50-day (SMA 50) and 200-day (SMA 200) moving averages are 0.11 and 0.12, respectively. This suggests the stock has recently moved above its longer-term averages but with limited momentum. The Average True Range (ATR) of 0.01 reflects low volatility. Given the , including a P/B ratio of 1.07 and a negative RoE of -32.11, the stock may face headwinds due to its current financial performance. However, the small market cap of 5.59M CAD could attract speculative interest if potash prices strengthen. Over the next 3 months, expect the stock to trade in a narrow range with potential for modest upside if fertilizer demand improves. Investors should monitor industry trends and company-specific developments closely.

Additional Sources for KRN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

KRN Stock Overview

Market Cap in USD 9m
Sector Basic Materials
Industry Agricultural Inputs
GiC Sub-Industry Fertilizers & Agricultural Chemicals
IPO / Inception

KRN Stock Ratings

Growth Rating -9.78
Fundamental -
Dividend Rating 0.0
Rel. Strength 50.8
Analysts -
Fair Price Momentum 0.21 CAD
Fair Price DCF -

KRN Dividends

No Dividends Paid

KRN Growth Ratios

Growth Correlation 3m 77.1%
Growth Correlation 12m -3.9%
Growth Correlation 5y -45.3%
CAGR 5y 3.31%
CAGR/Max DD 5y 0.04
Sharpe Ratio 12m -0.03
Alpha 38.47
Beta -1.449
Volatility 324.50%
Current Volume 0.5k
Average Volume 20d 6.2k
What is the price of KRN stocks?
As of May 10, 2025, the stock is trading at CAD 0.20 with a total of 500 shares traded.
Over the past week, the price has changed by -4.76%, over one month by +42.86%, over three months by +81.82% and over the past year by +42.86%.
Is Karnalyte Resources a good stock to buy?
Neither. Based on ValueRay Analyses, Karnalyte Resources is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -9.78 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KRN as of May 2025 is 0.21. This means that KRN is currently overvalued and has a potential downside of 5%.
Is KRN a buy, sell or hold?
Karnalyte Resources has no consensus analysts rating.
What are the forecast for KRN stock price target?
According to ValueRays Forecast Model, KRN Karnalyte Resources will be worth about 0.2 in May 2026. The stock is currently trading at 0.20. This means that the stock has a potential upside of +10%.
Issuer Forecast Upside
Wallstreet Target Price 0.9 325%
Analysts Target Price - -
ValueRay Target Price 0.2 10%